Perfil
Andrew Parker is currently the Chief Executive Officer of ArisGen SA and the Chief Executive Officer & Member-Supervisory Board of Step Pharma SAS. Previously, he worked as the General Partner & Scientific Director of Eclosion2 SA, Independent Director of GeNeuro SA (Switzerland), Scientific Director & General Partner of Eclosion2 & Cie Scpc, Principal at AstraZeneca PLC and Beerse Betonhandel, Vice President & Head-Exploratory Projects at Shire Plc, Chief Science Officer & Executive Vice President at Zealand Pharma A, Principal at Janssen Pharmaceutica NV, and Vice President-Pre Clinical Research at Opsona Therapeutics Ltd. Dr. Parker holds an MBA from Warwick Business School and a doctorate from The National Institute For Medical Research.
Cargos activos de Andrew Parker
| Empresas | Cargo | Inicio |
|---|---|---|
ArisGen SA
ArisGen SA Pharmaceuticals: MajorHealth Technology Manufactures novel products | Director Ejecutivo | - |
Step Pharma SAS
Step Pharma SAS Pharmaceuticals: MajorHealth Technology Develops drugs for immunosuppressive therapies | Director Ejecutivo | 05/09/2019 |
Antiguos cargos conocidos de Andrew Parker.
| Empresas | Cargo | Fin |
|---|---|---|
| ZEALAND PHARMA A/S | Director Técnico/Científico/I+D | 31/08/2019 |
Eclosion2 SA
Eclosion2 SA Financial ConglomeratesFinance Provides financial services | Corporate Officer/Principal | - |
Eclosion2 & Cie Scpc | Corporate Officer/Principal | - |
| SHIRE | Corporate Officer/Principal | - |
| GENEURO SA | Director/Miembro de la Junta | - |
Formación de Andrew Parker.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 13 |
|---|---|
AstraZeneca PLC
AstraZeneca PLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Warwick Business School
Warwick Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Shire Plc
Shire Plc Pharmaceuticals: MajorHealth Technology Develops and markets medicines for patients with rare diseases | Health Technology |
Beerse Betonhandel
Beerse Betonhandel Regional BanksFinance Functions Related To Depository Banking Not Elsewhere Classified | Finance |
Zealand Pharma A/S
Zealand Pharma A/S BiotechnologyHealth Technology Operates as a biotechnology company that discovers and develops peptide based medicines | Health Technology |
The National Institute For Medical Research
The National Institute For Medical Research Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Janssen Pharmaceutica NV
Janssen Pharmaceutica NV Pharmaceuticals: MajorHealth Technology Engages in research, development and production of drugs | Health Technology |
Opsona Therapeutics Ltd.
Opsona Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Provides immunology drug for treatment of inflammatory diseases | Health Technology |
Eclosion2 SA
Eclosion2 SA Financial ConglomeratesFinance Provides financial services | Finance |
ArisGen SA
ArisGen SA Pharmaceuticals: MajorHealth Technology Manufactures novel products | Health Technology |
GeNeuro SA (Switzerland)
GeNeuro SA (Switzerland) BiotechnologyHealth Technology Engages in the research and development of pharmaceutical products to treat neurological diseases | Health Technology |
Eclosion2 & Cie Scpc | |
Step Pharma SAS
Step Pharma SAS Pharmaceuticals: MajorHealth Technology Develops drugs for immunosuppressive therapies | Health Technology |
- Bolsa de valores
- Insiders
- Andrew Parker
















